- Home
- LVRO vs HUMA Comparison
LVRO vs HUMA Comparison
Compare LVRO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- HUMA
- Stock Information
- Founded
- LVRO 2017
- HUMA 2004
- Country
- LVRO Brazil
- HUMA United States
- Employees
- LVRO N/A
- HUMA N/A
- Industry
- LVRO Blank Checks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- HUMA Health Care
- Exchange
- LVRO Nasdaq
- HUMA Nasdaq
- Market Cap
- LVRO 279.6M
- HUMA 367.6M
- IPO Year
- LVRO N/A
- HUMA N/A
- Fundamental
- Price
- LVRO $2.11
- HUMA $2.11
- Analyst Decision
- LVRO Sell
- HUMA Strong Buy
- Analyst Count
- LVRO 3
- HUMA 7
- Target Price
- LVRO $1.88
- HUMA $13.00
- AVG Volume (30 Days)
- LVRO 6.8K
- HUMA 3.4M
- Earning Date
- LVRO 07-11-2025
- HUMA 08-12-2025
- Dividend Yield
- LVRO N/A
- HUMA N/A
- EPS Growth
- LVRO N/A
- HUMA N/A
- EPS
- LVRO N/A
- HUMA N/A
- Revenue
- LVRO $1,667,345,189.00
- HUMA $517,000.00
- Revenue This Year
- LVRO N/A
- HUMA N/A
- Revenue Next Year
- LVRO $12.46
- HUMA $896.45
- P/E Ratio
- LVRO N/A
- HUMA N/A
- Revenue Growth
- LVRO N/A
- HUMA N/A
- 52 Week Low
- LVRO $1.90
- HUMA $1.15
- 52 Week High
- LVRO $5.69
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- LVRO 37.54
- HUMA 45.56
- Support Level
- LVRO $1.94
- HUMA $2.13
- Resistance Level
- LVRO $2.29
- HUMA $2.30
- Average True Range (ATR)
- LVRO 0.19
- HUMA 0.16
- MACD
- LVRO -0.04
- HUMA -0.06
- Stochastic Oscillator
- LVRO 13.74
- HUMA 16.47
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.